Yale doctor creates new weapons to kill cancer – New Haven Register
New Haven Register |
Yale doctor creates new weapons to kill cancer
New Haven Register “When you use the DNA approach, that DNA gets incorporated into your genome, whereas the RNA doesn’t change your genome at all,” Katz said. “It has some safety considerations.” There are several other advantages of using RNA, Katz said. It takes far … |
New Haven Register |
Yale doctor creates new weapons to kill cancer
New Haven Register “When you use the DNA approach, that DNA gets incorporated into your genome, whereas the RNA doesn’t change your genome at all,” Katz said. “It has some safety considerations.” There are several other advantages of using RNA, Katz said. It takes far … |
|
Gene Therapy May Be Cure for ‘Bubble Boy’ Disease – WebMD
WebMD But after decades of research, doctors now believe they have created a cure for severe combined immunodeficiency (SCID). |
|
Gene Therapy May Be Cure for ‘Bubble Boy’ Disease – WebMD
WebMD But after decades of research, doctors now believe they have created a cure for severe combined immunodeficiency (SCID). |
EurekAlert (press release) |
Immunotherapy drug nearly eliminates severe acute graft-versus-host disease
EurekAlert (press release) “Given the serious threat of graft-versus-host disease, new approaches to make stem cell transplants safer for patients remain a critical unmet need,” said Dr. Leslie Kean, the trial’s principal investigator and associate director of the Ben Towne … |
EurekAlert (press release) |
Immunotherapy drug nearly eliminates severe acute graft-versus-host disease
EurekAlert (press release) “Given the serious threat of graft-versus-host disease, new approaches to make stem cell transplants safer for patients remain a critical unmet need,” said Dr. Leslie Kean, the trial’s principal investigator and associate director of the Ben Towne … |
|
Immunotherapy Drug for Rheumatoid Arthritis Nearly Eliminates Severe Acute Graft-Versus-Host Disease after …
PR Newswire (press release) “Given the serious threat of graft-versus-host disease, new approaches to make stem cell transplants safer for patients remain a critical unmet need,” said Dr. Leslie Kean, the trial’s principal investigator and associate director of the Ben Towne … |